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a  b  s  t  r  a  c  t
Human papillomavirus (HPV) has been found in several regions of the body, including the
oral  cavity. Recently, this virus has been associated with oropharyngeal cancer, but little
is  known about HPV transmission to the oral cavity. We  carried out a study to investigate
concurrent oral and cervical infections in 76 asymptomatic women attending a healthcare
program. Demographic and behavior data were obtained through a structured question-
naire. Oral and cervical mucosa scrapings were collected and stored for DNA extraction.
HPV  DNA ampliﬁcation was performed by polymerase chain reaction assay (PCR) using both
primers My09/My11 and FAP59/64, followed by HPV typing with restriction fragment length
polymorphism analysis (RFLP) and sequencing. The data collected revealed no risk factors
for  HPV infection in these 76 women. HPV prevalence of 9.2 and 5.3% was found in cervical
and  oral mucosa, respectively. Concurrent infections by discordant types were detected in
one  case only. Sequencing procedures allowed us to detect a new putative HPV 17 subtype
from  the Betapapillomavirus genus. Our results support the view that cervical and oral HPV
infections are independent events. The observed low prevalence of both oral and cervicalHPV  infections could be associated with attendance in a healthcare program.
©  2016 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. This is an
open  access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
Currently, three anti-HPV vaccines are commercially avail-uman papillomavirus species from Alpha,  Beta, and Gamma
enera have been found in oral cavities, but their trans-
ission mechanism remains unclear. Acquisition could be
hrough oral–genital or mouth-to-mouth contact, autoinocu-
ation, or an independent event.1 This matter is controversial,
nd Rautava and Syrjänen2 concluded that oral infectionPlease cite this article in press as: Oliveira LH, et al. Papillomavirus infect
Infect Dis. 2016. http://dx.doi.org/10.1016/j.bjid.2016.08.015
an be transmitted sexually, through kissing or by house-
old contact, or even by vertical transmission from mother
o child during childbirth. Vidotti et al.3 reported a signiﬁcant
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association between oral and genital HPV. On the other hand,
genital infection could not predispose to oral infection, even if
both sexual partners practiced oral sex.4 Oral HPV infections
are frequently asymptomatic, but in the last decade some
types were also associated with oropharyngeal cancer.5ions in the oral and genital mucosa of asymptomatic women. Braz J
able. Although clinical trials have shown high efﬁcacy in the
prevention of malignancies in uninfected women, the impact
of these vaccines on non-genital infections have not been
lsevier Editora Ltda. This is an open access article under the CC
.
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Table 1 – Distribution of HPV genital and oral genotypes.
Genital Oral
Types n Types n
31 1 6 2
52 1 17 1
61 1 Not typiﬁed 1
62 2
84 1
types. In line with our ﬁndings, a German research reported2  b r a z j i n f e c t d i s
determined yet.6 However, Herrero et al.7 stated that a biva-
lent vaccine is effective in preventing oropharyngeal cancer.
If vaccination is effective for some HPV types of the genital
area, it is quite possible that it also acts in other parts of the
body. The investigation of HPV genotypes in the cervical and
oral tract of asymptomatic women who  regularly attended a
health program may contribute to the knowledge of oral HPV
transmission.
We conducted a randomized, cross-sectional survey, ini-
tially investigating 351 sexually active women who were
referred to the Family Health Program in Niterói, Rio de Janeiro
State, from 2009 to 2010. Data about this study have been pub-
lished elsewhere.8
Out of the 351 participants, 84 asymptomatic women with-
out oral lesions agreed to participate in oral HPV tests. After
undergoing a routine gynecological examination, two cervical
specimens were collected from each participant for Papanico-
laou staining and HPV testing. None of the women had been
vaccinated against HPV. A scraping of the oral cavity from the
borders of the tongue and cheeks was also performed using
a sterile brush. Demographic data were obtained through a
structured questionnaire. The Ethics Committee of the College
of Medicine of the University provided ethical clearance for
the protocol and informed consent (CEP CMM/HUAP 052/2010,
CAAE 0037.0.258.000-10).
DNA was extracted from samples (High Pure PCR Tem-
plate Preparation Kit, Roche, São Paulo, Brazil) and quantiﬁed
(Thermo Scientiﬁc NanoDrop 2000 spectrophotometer, Wil-
mington, North Carolina, USA). Due to insufﬁcient DNA, eight
scrapings were discarded, remaining 76 samples. The quality
of DNA extracted was assessed by polymerase chain reac-
tion assay (PCR) ampliﬁcation of a 260 bp DNA fragment for
-globin using the primers PC04/GH20.9 Ampliﬁcation of HPV
DNA was done with MY09/11 consensus primers (Síntese
Biotecnologia, Belo Horizonte, MG), which amplify a 450 bp
in the L1 region of HPV DNA.10 To improve the sensitivity
of the assay to detect oral HPV, a second PCR system using
the primers FAP59/6411 (Síntese Biotecnologia, Belo Horizonte,
MG)  was added. These primers amplify a 480 bp within the
same L1. All oral samples were submitted to My09/11 and
FAP/64 systems. Although MY09/11 degenerate primers are
routinely and largely used to detect mucosal HPV (Alpha
species), especially from genital mucosa, the FAP 59/64 sys-
tem has been applied in the detection of cutaneous HPV (Beta
and Gamma  species) and has been used to improve detection
of oral HPV.12 The combination of these systems tracks a broad
range of types, even types not yet identiﬁed.
HPV typing was performed by restriction fragment length
polymorphism analysis (RFLP) or sequencing. For RFLP analy-
sis, the resultant 450 base pairs PCR products were digested
by six restriction enzymes (BamHI, DdeI, HaeIII, HinfI, PstI,
RsaI; Invitrogen, São Paulo, Brazil). The RFLP pattern of each
sample was analyzed by agar gel electrophoresis under ultra-
violet light and compared with the RFLP patterns for mucosal
HPV.13 The smears that could not be typiﬁed by RFLP assay
were submitted to sequencing. The ampliﬁed PCR product
was puriﬁed and directly sequenced in an ABI DNA 3130Please cite this article in press as: Oliveira LH, et al. Papillomavirus infect
Infect Dis. 2016. http://dx.doi.org/10.1016/j.bjid.2016.08.015
sequencer (Applied Biosystems, California, USA) with the
same primers as those used for PCR ampliﬁcation. The for-
ward and reverse sequences were aligned and analyzed usingNot typiﬁed 1
7 4
ClustalW in BioEdit Sequence Alignment Editor (North Car-
olina State University, Raleigh, NC).14 Similarity analysis was
performed using BLAST (Alignment Search Tool Analysis).15
Types that could not be classiﬁed by any methods were con-
sidered to be unidentiﬁed. A databank was generated in the
SPSS-18 statistical package. Chi-Square (2) or Fisher’s exact
test were applied to compare categorical variables. t-Tests
were used for comparing age means among groups. To identify
associations between possible risk factors and the presence of
HPV, odds ratios (OR) with 95% conﬁdence intervals (95% CI)
were calculated. For all tests, the level of signiﬁcance was set
at 0.05.
The participants who enrolled in this study were aged 14
through 70 years, with a mean age of 37.26 years and standard
deviation of 14.59; 60.5% of the women were over 30 years old.
Most of them received a monthly family income of over U$ 600,
and 63.2% had attended only elementary school or reported
being illiterate. Non-white people were the most prevalent
ethnic group (69.7%). Most of the women maintained a stable
sexual partner and had up to three lifetime sexual partners,
with one partner during the last three months. Nearly half
had begun their sexual activity before the age of 17. Sixty-six
percent and 52.50% of the women had never used cigarettes
or alcohol, respectively. Condoms were not used by 78.9%, but
other contraceptive methods were employed by 84.2% of them.
Parity up to two children was reported by 69.2% of the women,
of whom 32.8% reported abortion episodes.
At the time of the interview, most of the participants
(81.6%) had no history of any sexually transmitted disease.
The remaining people reported past vulvar condyloma (7),
syphilis seropositivity (4), candidiasis (2), and chlamydia (1).
No women reported being HIV positive. Most of these women
were submitted to regular gynecological examinations (93.4%).
The cervical oncologic cytology smear from 94.7% of the
participants was normal or inﬂammatory. The results show
that a predominantly healthy population concerning cervical
lesions, risk factors for HPV infection, and sexually transmit-
ted diseases was screened. Therefore, educational support
from basic healthcare staff could be associated with the proﬁle
of this population.
Genital and oral HPV were present in 9.2 and 5.3% of the
women, respectively. The cervical and oral types are shown
in Table 1. Each site harbored types totally discordant and the
only woman HPV positive for both sites harbored different HPVions in the oral and genital mucosa of asymptomatic women. Braz J
that HPV oral autoinoculation and transmission to sexual
partners were uncommon events in 60 cervical HPV-positive
women.16 Similarly, Kero et al.17 concluded that although oral
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1b  r a z j i n f e c t d i s .
nd genital HPV infections are common in current partners,
he low concordance of types supports the hypothesis that
he current HPV types had been established long before the
urrent relationship. Our results support this statement.
The high-risk type 16, frequently detected in both sites,
as missing in this population. We  also had not found HPV
6 in a previous research on oral HPV detection enrolling 77
IV-infected people and 120 healthy controls.18 Other authors
ave described the low or rare prevalence of HPV 16 in the oral
avity.19,20 In a Brazilian study, HPV genotypes 6 and 11 were
he types most commonly detected in the oral mucosa. Type
6 was only found in one sample (Cordeiro TI, not published).
PV 61, 62, and 84, tracked in this study, are infrequent and
robably transient. Interestingly, only one out of seven women
ith past condyloma harbored genital HPV infection (type 62),
onﬁrming the self-limited nature of these lesions as well as
he transient character of low risk HPV associated with them.
n the vaccination era, such information can be helpful.
Despite the sensitivity of the methods used for viral
etection, which may be affected by factors such as DNA con-
entration and purity, the combination of two primer sets
as successful. We  obtained 10 infected samples using the
rimers My09/11, seven of which were positive for cervical
PV and three positive for oral HPV. The three positive sam-
les for MY  PCR were also positive for FAP/64 PCR. One of
hem, which could not to be identiﬁed by RFLP, was typiﬁed
y FAP/64 PCR followed by sequencing as type 6. One sample
as exclusively detected by FAP/64 PCR, and the sequencing
evealed an unidentiﬁed type genetically close to the genus
etapapillomavirus.
We detected a new putative HPV 17 subtype in the oral
avity using the primers My09/11. The partial analysis of the
1 DNA sequence showed a genome not very close to the
rototype. Although two subtypes (“a” and “b”) have been
escribed for HPV 17, the alignment of these regions with
nown sequences showed a dissimilarity higher than 2%. Iso-
ates difference between ≥90% and ≤98% identity in the partial
1 sequence are considered subtypes, but the ﬁnal result will
e deﬁned by the total sequence.
In conclusion, our results suggest that oral HPV infection
s unlikely to be acquired through autoinoculation. Oral HPV
nfection is rather an independent event from cervical infec-
ion, strengthening the hypothesis of different transmission
outes. The low prevalence of both infections was proba-
ly linked to compliance with guideline recommendations
egarding practices to avoid sexually transmitted diseases.
herefore, we  hope that HPV vaccination does not compro-
ise cervical cancer control screening programs. The ﬁnding
f a new putative oral HPV 17 subtype underscores the large
pectrum of viral variants in the oral cavity.
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